Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLES
In the ever-changing world of pharmaceuticals and biotech, companies are continually seeking strategies to optimize their safety and regulatory compliance. One such strategy that has gained significant traction is outsourcing. A staggering 67% of biotech and pharma companies outsource their pharmacovigilance operations, and 54% outsource their regulatory activities. This trend is even more pronounced among emerging biopharma (EBP) companies, with 62% outsourcing regulatory activities. Outsourcing is not limited to services alone. Companies are increasingly recognizing the importance of technology in their operations. A majority of biotech and pharma companies are monitoring the development of the latest technologies affecting outsourcing regulatory activities. Furthermore, 59% of these companies consider technology when selecting an outsourcing vendor for regulatory activities. This trend is reflected in the fact that 79% of biopharma companies are either testing or using an established combination of AI agents and human experts in various configurations. |
![]() |
However, while outsourcing is a commonly accepted solution for many pharma companies, using more than one vendor can create significant challenges. Services and technology need to work in tandem, and handing these functions off to multiple vendors can result in confusion, inefficiency, and suboptimal results. Unfortunately, many pharmaceutical and biotech companies find themselves juggling multiple vendors, with 49% outsourcing pharmacovigilance services and technology to three to four vendors, and 11% outsourcing to five or more vendors.
Despite these challenges, most life sciences company leaders acknowledge that outsourcing to just one vendor could be a better way to go. Only 16% of biotech and pharma companies feel that relying on a single vendor is a concern when considering combined PV solutions. Moreover, 89% of these companies plan to outsource combined PV solutions in the future.
Using just one vendor can be an agile, efficient, and cost-effective option, mitigating many of the risks associated with using multiple partners. Conducting all operations via the same outsourcing company creates a comprehensive feedback loop, helping both the technology and service teams improve, thanks to the data gathered by each. With just one vendor, it’s easier to implement and follow standard operating procedures. Plus, one vendor can respond to customer needs and changing regulatory requirements with more agility than two independent vendors.
In conclusion, the power of a single, integrated vendor partner cannot be overstated. Companies can optimize their pharmacovigilance operations, increase efficiencies, and most importantly, enhance patient safety. A single-vendor approach in regulatory affairs not only promotes operational efficiency but also increases agility in responding to changing regulatory requirements.
To learn more about the benefits of outsourcing and the power of a single-vendor approach, download the full infographic here. Harness the power of integrated services and technology solutions with IQVIA, a leading global provider of safety and regulatory compliance solutions.